Prolonged SARS-CoV-2 viral shedding in patients with solid tumors and associated factors
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
SARS-CoV-2 is a highly contagious virus and can cause potentially fatal complications in cancer patients; Until now, the most accurate and common methods to detect active viral infection are: (1) a positive RT-PCR, (2) a serological test (IgM+ and IgG-), (3) or a positive antigen test. Previous studies have characterized time length of viral shedding in immunocompetent patients; however, there are scarce reports on immunosuppressed cancer patients. Aydillo et al. studied shedding of viable SARS-CoV-2 in transplanted hematological patients or those receiving CAR-T cell therapy. In fact, the CDC's recommendations for this patient profile is still based on limited data. Thus, we aim to study SARS-CoV-2 viral shedding in patients with solid tumors and its associated factors.
European Journal of Cancer , éditorial en libre accès, 2020